Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis
Authors
Keywords
Endothelial dysfunction, von Willebrand Factor, Tissue-type plasminogen activator, Plasminogen activator inhibitor-1, Thrombomodulin, COVID-19
Journal
MICROVASCULAR RESEARCH
Volume 138, Issue -, Pages 104224
Publisher
Elsevier BV
Online
2021-07-15
DOI
10.1016/j.mvr.2021.104224
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
- (2020) Julie Helms et al. INTENSIVE CARE MEDICINE
- Hypercoagulability of COVID‐19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis
- (2020) Mauro Panigada et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19
- (2020) Claire S Whyte et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science
- (2020) Paul C Evans et al. CARDIOVASCULAR RESEARCH
- Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?
- (2020) Eleni E Ladikou et al. CLINICAL MEDICINE
- Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19
- (2020) Ying X Gue et al. EUROPEAN HEART JOURNAL
- Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
- (2020) Alice Huertas et al. EUROPEAN RESPIRATORY JOURNAL
- In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation
- (2020) Annabel Blasi et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosis
- (2020) Christophe Nougier et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection: Time to Rethink
- (2020) Nuccia Morici et al. THROMBOSIS AND HAEMOSTASIS
- Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
- (2020) George Goshua et al. Lancet Haematology
- Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia
- (2020) Francesco Taus et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Endothelial dysfunction in COVID-19: Current findings and therapeutic implications
- (2020) Matthias P. Nägele et al. ATHEROSCLEROSIS
- Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses
- (2020) Eleni Gavriilaki et al. CURRENT HYPERTENSION REPORTS
- Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19
- (2020) Coraline Radermecker et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID‐19
- (2020) Antoine Rauch et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome
- (2020) Sujin Kang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
- (2020) Daniel E Leisman et al. Lancet Respiratory Medicine
- Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients
- (2020) D.J. Hoechter et al. THROMBOSIS RESEARCH
- Endothelial cells of different organs exhibit heterogeneity in von Willebrand factor expression in response to hypoxia
- (2019) Anahita Mojiri et al. ATHEROSCLEROSIS
- Thrombotic Regulation From the Endothelial Cell Perspectives
- (2018) Miao Wang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A biophysical view on von Willebrand factor activation
- (2017) Achim Löf et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
- (2015) Xiang Wan et al. BMC Medical Research Methodology
- Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects
- (2013) Fiona A. Martin et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Ratio of von Willebrand Factor Propeptide to ADAMTS13 Is Associated With Severity of Sepsis
- (2013) Hidetada Fukushima et al. SHOCK
- Plasma ADAMTS13, von Willebrand Factor (VWF) and VWF Propeptide Profiles in Patients with DIC and Related Diseases
- (2011) Koji Habe et al. THROMBOSIS RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started